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The authors report a randomized trial comparing the benefits
of strength training (ST) and walking training (WT) in patients
with intermittent claudication. The study uses standard outcome
measures to objectively quantify improvements in ambulation and
physiological function, including walking distance, oxygen con-
sumption, walking economy, ischemic window, and leg strength.
It also raises questions about the underlying cause of exercise-
induced discomfort and the value of potential new therapeutic
alternatives.
The authors modified previously reported exercise therapy
protocols, proposing another possible option for the treatment of
claudication. It is becoming clear from basic science studies1 and
clinical trials2 that significant abnormalities are present in the lower
extremity musculature, leading to altered gait. The authors suc-
cinctly point to these abnormalities as a justification for the use of
ST to improve ambulatory function. The exact nature of the
abnormalities, and their effect on gait, is becomingmore evident as
information accumulates from recent large-scale studies docu-
menting the presence of a lower extremity strength deficit in
patients with peripheral arterial disease (PAD).3 Advanced biome-
chanical analyses are also beginning to delineate the contribution
of individual muscle groups to the gait abnormalities associated
with PAD in a limited number of patients.2,4
In contrast to previous studies that have relied on a predeter-
mined level of ambulatory effort, and to compare ST and WT, the
current protocol uses perceived exertion measured by the validated
Borg scale to determine therapeutic effort. This approach is new
within the supervised exercise literature; however, perceived exer-
tion in exercise provides a relatively stable measure of work unre-
lated to objective measurements, especially in elite athletes.5 Inter-
estingly, patients in the current study had a perceived exertion thatOmaha, Neb
suggesting a potential need to standardize patient effort in future
trials.
Although the current results demonstrate significant improve-
ment in ambulation with both protocols, to conclude that ST is
comparable to WT from these results and those of related studies
would be inappropriate. Despite previously well-designed and
executed trials comparing supervisedWTwith ST, very little can be
concluded based on the significant variations in conduct and
outcome measures. The current study, in the context of recent
literature, clearly illustrates the need for standardization. For the
field of PAD treatment to progress, common outcome measures
need to be agreed upon and reported to allow for accurate com-
parisons among the myriad of medical, exercise, and operative
treatments available.
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